Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Division of Physical Medicine and Rehabilitation, University of British Columbia, Vancouver, BC, Canada.
Can J Neurol Sci. 2020 Nov;47(6):834-838. doi: 10.1017/cjn.2020.108. Epub 2020 Jun 4.
Successful management of focal spasticity requires access to botulinum toxin type A (BoNT-A) injections, physiotherapy, occupational therapy, and orthoses/bracing. To assess the quality of focal spasticity care across Canada, we sent a survey consisting of 22 questions to physiatrists involved in the management of outpatient spasticity. Thirty-four physiatrists from all 10 provinces responded to the survey. Wait time for BoNT-A treatment averaged 12.7 weeks from time of referral across Canada. More than 75% of patients faced barriers to obtaining physical therapy and orthoses. Access to best quality care for spasticity patients across Canada varies widely.
成功管理局灶性痉挛需要获得肉毒毒素 A 型(BoNT-A)注射、物理治疗、职业治疗和矫形器/支具。为了评估加拿大各地局灶性痉挛护理的质量,我们向参与门诊痉挛管理的物理治疗师发送了一份包含 22 个问题的调查。来自加拿大所有 10 个省的 34 名物理治疗师对调查做出了回应。从转诊到接受 BoNT-A 治疗的平均等待时间在加拿大各地为 12.7 周。超过 75%的患者在获得物理治疗和矫形器方面存在障碍。加拿大各地痉挛患者获得最佳质量护理的机会差异很大。